Advancis Pharmaceutical (AVNC) Announces $24 Million Private Placement of Common Equity
More News related to AVNC
- Advancis Pharmaceutical (AVNC) Concludes Pre-Phase III Meeting with FDA for Development of Keflex PULSYS Product Candidate
- StreetInsider.com Unusual 11 Mid-Day Movers 05/22/2007
- StreetInsider.com Pre-Open Movers 05/22
- Advancis Pharmaceutical (AVNC) Receives FDA Acceptance of Amoxicillin PULSYS NDA
- Advancis Pharmaceutical (AVNC) Announces $24 Million Private Placement of Common Equity
Advancis Pharmaceutical Corporation (Nasdaq: AVNC) has entered into definitive purchase agreements for the private placement of 10,155,000 shares of its common stock and warrants to purchase 7,616,250 shares of common stock, at a price of $2.36375 per unit. Each unit consists of one share of the Company's common stock and a warrant to purchase 0.75 shares of common stock. The transaction is expected to raise approximately $24 million in gross proceeds.
Related Categories
Equity OfferingsStocks Mentioned
-0.11Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
